Publications
- Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries2018 | Third Faculty of Medicine, First Faculty of Medicine
- Vliv adalimumabu na biomarkery kardiovaskulárního rizika u pacientů s psoriázou2017 | Third Faculty of Medicine
- Successful Treatment of Severe Hidradenitis Suppurativa with Adalimumab2011 | Third Faculty of Medicine
- Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy2010 | Third Faculty of Medicine
- Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic2024 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Atopic Dermatitis: Current Recommendations for Diagnosis and Treatment. Part I2023 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- BIOREP - Biologic/Targeted Therapy Registry: 2022 Summary Report2023 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Atopic Dermatitis: Current Guidelines for Diagnosis and Treatment. Part II2023 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry2023 | Third Faculty of Medicine, First Faculty of Medicine
- On the question of the interchangeability of monoclonal biosimilar antibodies in the treatment of immune-mediated inflammatory diseases2023 | Third Faculty of Medicine, First Faculty of Medicine
Loading network view...